Novartis Japan Unit Finds 10,000 Unreported Side-Effects Cases In Probe
This article was originally published in PharmAsia News
Executive Summary
Novartis Pharma K.K. told Japan regulators its in-house investigation of failures of its Japan operations uncovered a more than decade-long failure to report as many as 10,000 incidents of serious side effects with its drugs.